Jay Lichter - Net Worth and Insider Trading
Jay Lichter Net Worth
The estimated net worth of Jay Lichter is at least $778 Million dollars as of 2024-12-03. Jay Lichter is the Director, 10% Owner of Synthorx Inc and owns about 7,567,513 shares of Synthorx Inc (THOR) stock worth over $515 Million. Jay Lichter is the 10% Owner of Janux Therapeutics Inc and owns about 6,560,816 shares of Janux Therapeutics Inc (JANX) stock worth over $264 Million. Jay Lichter is also the Director of Otonomy Inc and owns about 0 shares of Otonomy Inc (OTIC) stock worth over $0. Details can be seen in Jay Lichter's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jay Lichter has not made any transactions after 2024-09-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jay Lichter
Jay Lichter Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jay Lichter owns 4 companies in total, including Otonomy Inc (OTIC) , Synthorx Inc (THOR) , and Aratana Therapeutics Inc (PETX) among others .
Click here to see the complete history of Jay Lichter’s form 4 insider trades.
Insider Ownership Summary of Jay Lichter
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| OTIC | Otonomy Inc | 2021-03-03 | director |
| THOR | Synthorx Inc | 2020-01-23 | director |
| PETX | Aratana Therapeutics Inc | 2015-07-15 | director |
 | | 2024-09-13 | director & 10 percent owner |
Jay Lichter Latest Holdings Summary
Jay Lichter currently owns a total of 3 stocks. Among these stocks, Jay Lichter owns 7,567,513 shares of Synthorx Inc (THOR) as of December 11, 2018, with a value of $515 Million and a weighting of 66.12%. Jay Lichter owns 6,560,816 shares of Janux Therapeutics Inc (JANX) as of September 13, 2024, with a value of $264 Million and a weighting of 33.88%. Jay Lichter also owns 0 shares of Otonomy Inc (OTIC) as of March 3, 2021, with a value of $0 and a weighting of 0%.
Latest Holdings of Jay Lichter
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| THOR | Synthorx Inc | 2018-12-11 | 7,567,513 | 67.99 | 514,515,209 |
| JANX | Janux Therapeutics Inc | 2024-09-13 | 6,560,816 | 40.18 | 263,613,587 |
| OTIC | Otonomy Inc | 2021-03-03 | 0 | 0.01 | 0 |
Holding Weightings of Jay Lichter
Jay Lichter Form 4 Trading Tracker
According to the SEC Form 4 filings, Jay Lichter has made a total of 0 transactions in Synthorx Inc (THOR) over the past 5 years. The most-recent trade in Synthorx Inc is the acquisition of 545,455 shares on December 11, 2018, which cost Jay Lichter around $6 Million.
According to the SEC Form 4 filings, Jay Lichter has made a total of 3 transactions in Janux Therapeutics Inc (JANX) over the past 5 years, including 1 buys and 2 sells. The most-recent trade in Janux Therapeutics Inc is the sale of 3,815 shares on September 13, 2024, which brought Jay Lichter around $178,084.
According to the SEC Form 4 filings, Jay Lichter has made a total of 3 transactions in Otonomy Inc (OTIC) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Otonomy Inc is the sale of 321,180 shares on March 3, 2021, which brought Jay Lichter around $867,186.
Insider Trading History of Jay Lichter
- 1
Jay Lichter Trading Performance
GuruFocus tracks the stock performance after each of Jay Lichter's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jay Lichter is 17.63%. GuruFocus also compares Jay Lichter's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jay Lichter within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jay Lichter's insider trading performs compared to the benchmark.
Performance of Jay Lichter
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 18.78 | | | | | |
| Relative Return to S&P 500(%) | 16.2 | | | | | |
Jay Lichter Ownership Network
Jay Lichter Owned Company Details
What does Otonomy Inc do?
Who are the key executives at Otonomy Inc?
Jay Lichter is the director of Otonomy Inc. Other key executives at Otonomy Inc include Chief Scientific Officer Alan Charles Foster , director & President & CEO David Allen Weber , and CFO/Ch. Business Offcr & Sec. Paul E Cayer .
Otonomy Inc (OTIC) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Otonomy Inc (OTIC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Otonomy Inc (OTIC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Otonomy Inc (OTIC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Otonomy Inc Insider Transactions
Jay Lichter Mailing Address
Above is the net worth, insider trading, and ownership report for Jay Lichter. You might contact Jay Lichter via mailing address: C/o Aratana Therapeutics, Inc., 11400 Tomahawk Creek Parkway, Suite 340, Leawood Ks 66211.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
